SK Bioscience Co Ltd - ESG Rating & Company Profile powered by AI
The SDG assessment for SK Bioscience Co Ltd indicates its reporting of the UN SDGs. The webpage of SK Bioscience Co Ltd is prepared by All Street Sevva using advanced Cognitive Robots. This report of SK Bioscience Co Ltd incorporates data from across the internet as well as from available disclosures by SK Bioscience Co Ltd.
SK Bioscience Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.5; made up of an environmental score of 2.0, social score of 2.0 and governance score of 3.4.
2.5
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1481 | Tissue Regenix Group PLC | 2.6 | Medium |
1481 | Twist Bioscience Corp | 2.6 | Medium |
1499 | SK Bioscience Co Ltd | 2.5 | Medium |
1499 | Akeso Inc | 2.5 | Medium |
1499 | Allergan plc | 2.5 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does SK Bioscience Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does SK Bioscience Co Ltd disclose current and historical energy intensity?
Does SK Bioscience Co Ltd report the average age of the workforce?
Does SK Bioscience Co Ltd reference operational or capital allocation in relation to climate change?
Does SK Bioscience Co Ltd disclose its ethnicity pay gap?
Does SK Bioscience Co Ltd disclose cybersecurity risks?
Does SK Bioscience Co Ltd offer flexible work?
Does SK Bioscience Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does SK Bioscience Co Ltd disclose the number of employees in R&D functions?
Does SK Bioscience Co Ltd conduct supply chain audits?
Does SK Bioscience Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does SK Bioscience Co Ltd conduct 360 degree staff reviews?
Does SK Bioscience Co Ltd disclose the individual responsible for D&I?
Does SK Bioscience Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does SK Bioscience Co Ltd disclose current and / or historical scope 2 emissions?
Does SK Bioscience Co Ltd disclose water use targets?
Does SK Bioscience Co Ltd have careers partnerships with academic institutions?
Did SK Bioscience Co Ltd have a product recall in the last two years?
Does SK Bioscience Co Ltd disclose incidents of discrimination?
Does SK Bioscience Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has SK Bioscience Co Ltd issued a profit warning in the past 24 months?
Does SK Bioscience Co Ltd disclose parental leave metrics?
Does SK Bioscience Co Ltd disclose climate scenario or pathway analysis?
Does SK Bioscience Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does SK Bioscience Co Ltd disclose the pay ratio of women to men?
Does SK Bioscience Co Ltd support suppliers with sustainability related research and development?
Does SK Bioscience Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does SK Bioscience Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is SK Bioscience Co Ltd involved in embryonic stem cell research?
Does SK Bioscience Co Ltd disclose GHG and Air Emissions intensity?
Does SK Bioscience Co Ltd disclose its waste policy?
Does SK Bioscience Co Ltd report according to TCFD requirements?
Does SK Bioscience Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does SK Bioscience Co Ltd disclose energy use targets?
Does SK Bioscience Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does SK Bioscience Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for SK Bioscience Co Ltd
These potential risks are based on the size, segment and geographies of the company.
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.